Avandia

  • Avandia

    Rosiglitazone (Avandia) is widely used to treat patients with type 2 diabetes mellitus, but its effect on cardiovascular morbidity and mortality has not been determined.

  • With this medicines safety now in question, in the light of recent scientific evidence that it poses increased risk of heart attack, it seems that the medicine's regulator may be putting the interests of the drugs industry before patients.